SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-318230
Filing Date
2019-12-19
Accepted
2019-12-19 07:00:56
Documents
4
Period of Report
2019-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d805386d8k.htm 8-K 18604
2 EX-99.1 d805386dex991.htm EX-99.1 15839
3 GRAPHIC g805386g1219045723591.jpg GRAPHIC 3194
4 GRAPHIC g805386g1219045723747.jpg GRAPHIC 3163
  Complete submission text file 0001193125-19-318230.txt   44623
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 191294120
SIC: 2834 Pharmaceutical Preparations